Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (TSE:CRON)
TSX:CRON
Cronos Group (CRON) Stock Price & Analysis
390 Followers
CRON Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$2.15 - C$4.01
Previous CloseC$3.4
Volume218.16K
Average Volume (3M)227.51K
Market Cap
C$1.30B
Enterprise ValueC$114.96M
Total Cash (Recent Filing)$861.53M
Total Debt (Recent Filing)$2.55M
Price to Earnings (P/E)-12.9
Beta0.70
Next Earnings
May 09, 2024EPS Estimate
-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding381,298,853
10 Day Avg. Volume221,134
30 Day Avg. Volume227,508
Standard Deviation0.15
R-Squared0.11
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.89
Price to Sales (P/S)15.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.80
Enterprise Value/Gross Profit9.04
Enterprise Value/Ebitda-5.12
Forecast
1Y Price Target
C$3.15Price Target Upside-10.65% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Cronos Group News
PremiumCompany Announcements
Cronos Group Schedules 2024 Virtual Shareholders Meeting
Bulls Say, Bears Say
Bulls Say
Product SuccessCronos's recent success with innovative value-add products under the Spinach brand highlights the company's potential to leverage these offerings in the expansive US market.
Regulatory ChangesCannabis stocks rally on growing optimism for reform with expected positive impact from German and Israeli rule changes on medical cannabis sales and potential Canadian regulatory alterations.
Strategic MergersThe prospect of a strategic merger with a brighter outlook cannabis company could spell upside for Cronos shareholders, especially if the transaction is done in stock.
Bears Say
Company PerformanceCronos' recent financial results have not bolstered confidence in its ability to create long-term value, with last quarter's trends showing a decline in gross margins and high selling, general, and administrative expenses.
Legislative EnvironmentAnalyst remains cautious on US reform, as election years typically contribute to legislative gridlock in Congress, potentially impacting the progress and expectations in the cannabis industry.
Regional InstabilityOngoing conflict and heightened competition in Israel have resulted in a gross margin miss for the quarter, leading to downward revisions in sales forecasts for the region.
---
Options Prices
Currently, No data available
---
Ownership Overview
92.81% Insiders
1.74% Mutual Funds
5.25% Other Institutional Investors
0.20% Public Companies and
Individual Investors
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$2.15 and its highest was C$4.01 in the past 12 months.
What is Cronos Group’s market cap?
Currently, no data Available
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is May 09, 2024 which is in 12 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Feb 29, 2024. The company reported -C$0.164 earnings per share for the quarter, missing the consensus estimate of -C$0.059 by -C$0.105.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Overvalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is -C$0.01.
How many shares outstanding does Cronos Group have?
Cronos Group has 381,298,860 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of -C$0.164 in its last earnings report, missing expectations of -C$0.059. Following the earnings report the stock price went down -6.579%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
---
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
C$3.15 (-10.65% Downside)
C$3.15 (-10.65% Downside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 84%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▲ 1.3%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.04%
12-Months-Change
Fundamentals
Return on Equity
-6.34%
Trailing 12-Months
Asset Growth
-6.01%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q4 2024
0:00 / 0:00
---
CRON Stock 12 Months Forecast
Average Price Target
C$3.15
▼(-10.65% Downside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
12/19 ratings generated profit
1 Year Average Return
+14.10%
reiterated a buy rating 9 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +14.10% per trade.
---